secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMERICA INC (BMRA)
CIK:        0000073290
Form:       8-K
Filed at:   2026-06-04T20:45:41+00:00
Accession:  0001493152-26-027290
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biomerica sells Diagnosis stake for $500k to CEO-affiliated buyers; note forgivable on transfer
--------------------------------------------------------------------------------

- Biomerica sells its 6% stake in Diagnosis S.A. (78,750 shares) to CEO-affiliated entities for $500,000.
- CEO Zackary Irani directly acquires $300,000 of the shares; two LLCs buy $200,000 total.
- Payments initially made via secured promissory note at 8% interest, due in 12 months; note forgiven upon share transfer.
- Transfer requires Polish regulatory approvals expected within 30 days after closing.
- Biomerica received $52,000 dividend from Diagnosis in 2026, disclosed to buyers prior to sale.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/73290/000149315226027290/0001493152-26-027290-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/73290/000149315226027290/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-027290

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer